Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Development of a novel class of targeted covalent inhibitors for the treatment of AML and other aggressive cancers
While significant progress has been made in the treatment of certain cancers, many cancers including acute myeloid leukemia and brain cancers, remain largely untreatable. We are developing unique small molecule-based synthetic therapies, which are expected to deliver more effective and less toxic therapies aggressive cancers.
Faculty Supervisor:
Patrick Gunning
Student:
Partner:
DTX Biotech (Mississauga, ON);DTX Biotech (Charlottetown, PEI)
Discipline:
Physics
Sector:
Professional, scientific and technical services
University:
University of Toronto; University of Toronto Mississauga
Program:
Accelerate
Current openings
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find Projects
International
Load More
International
Load More
